医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
14期
25-26
,共2页
陈涛%潘爱珍%黄慧玲%周嫦英%余田
陳濤%潘愛珍%黃慧玲%週嫦英%餘田
진도%반애진%황혜령%주항영%여전
小肝癌%射频消融%体层摄影术
小肝癌%射頻消融%體層攝影術
소간암%사빈소융%체층섭영술
Hepatocel ular Carcinoma%radiofrequency ablation%X-ray computed%tomography
目的:探讨原发性小肝癌射频消融治疗后,CT灌注扫描对肿瘤残留及复发的早期评价价值。方法在28例小肝癌患者行RFA治疗后的第1、3、6、12个月行CT常规增强及灌注扫描,并与随访/穿刺病理结果对照分析。结果 RFA术后第1个月,25例瘤灶呈坏死样低灌注,其中6例见稍高灌注环;3例见灶周结节样高灌注区,后证实为肿瘤残留。术后第3、6、12月,7例见灶周结节样高灌注区,后经证实均为复发灶,其中3例常规增强扫描未发现。结论 C T灌注扫描对小肝癌射频消融术后肿瘤残留及复发具有重要的早期诊断价值。
目的:探討原髮性小肝癌射頻消融治療後,CT灌註掃描對腫瘤殘留及複髮的早期評價價值。方法在28例小肝癌患者行RFA治療後的第1、3、6、12箇月行CT常規增彊及灌註掃描,併與隨訪/穿刺病理結果對照分析。結果 RFA術後第1箇月,25例瘤竈呈壞死樣低灌註,其中6例見稍高灌註環;3例見竈週結節樣高灌註區,後證實為腫瘤殘留。術後第3、6、12月,7例見竈週結節樣高灌註區,後經證實均為複髮竈,其中3例常規增彊掃描未髮現。結論 C T灌註掃描對小肝癌射頻消融術後腫瘤殘留及複髮具有重要的早期診斷價值。
목적:탐토원발성소간암사빈소융치료후,CT관주소묘대종류잔류급복발적조기평개개치。방법재28례소간암환자행RFA치료후적제1、3、6、12개월행CT상규증강급관주소묘,병여수방/천자병리결과대조분석。결과 RFA술후제1개월,25례류조정배사양저관주,기중6례견초고관주배;3례견조주결절양고관주구,후증실위종류잔류。술후제3、6、12월,7례견조주결절양고관주구,후경증실균위복발조,기중3례상규증강소묘미발현。결론 C T관주소묘대소간암사빈소융술후종류잔류급복발구유중요적조기진단개치。
Objective To evaluate the feasibil ty of CT perfusion imaging (CTPI) in finding tumor residual / recurrent after radiofrequency ablation (RFA) of smal hepatocel ular carcinoma (SHCC). Methods Al twenty-eight SHCC lesions underwent conventional enhanced and perfusion CT examination at the first, third, sixty and twelfth month post-RFA. Results At the first month post-RFA, 25 cases showed total necrosis with low perfusion, while 6 cases showed slightly high perfusion on the periphery area, 3 cases showed local tumor residual. At the third, sixty and twelfth month post-RFA, 25 total necrosis lesions shrinked, while 7 cases with high perfusion nodules were found, which were proved as tumor recurrence. Conclusion CT perfusion imaging (CTPI) can help to discover post-RFA local tumor residual and recurrence.